Increasing the number of intestinal endocrine L-cells According to the impairment of L-cells development in T2DM, a promising strategy for treating T2DM is to increase the number of L-cells in the intestine, thereby increasing the production of GLP-1
FDA Approval and Use Ozempic is approved for managing blood sugar and can also reduce heart risks in people with heart disease, while Mounjaro is FDA-approved for managing type 2 diabetes with its dual action on receptors
Rotation day (for aliquoted protocols): Move next frozen aliquot to fridge the evening before the current aliquot runs out
5 Here we summarized the complex mechanisms of GLP-1RAs and their latest advancements in treating various diseases, such as musculoskeletal inflammation, obesity, cardiovascular diseases, NAFLD, neurodegenerative diseases, and various cancers
Bray, X
Mixing protein powder in Fairlife instead of water adds 13g protein to every shake turning a 25g shake into a 38g shake